Structure-based design of a cyclophilin-calcineurin bridging ligand.

The affinity of a flexible ligand that adopts a specific conformation when bound to its receptor should be increased with the appropriate use of conformational restraints. By determining the structure of protein-ligand complexes, such restraints can in principle be designed into the bound ligand in a rational way. A tricyclic variant (TCsA) of the immunosuppressant cyclosporin A (CsA), which inhibits the proliferation of T lymphocytes by forming a cyclophilin-CsA-calcineurin complex, was designed with the known three-dimensional structure of a cyclophilin-CsA complex. The conformational restraints in TCsA appear to be responsible for its greater affinity for cyclophilin and calcineurin relative to CsA.

[1]  T. Soderling,et al.  NF-ATp, a T lymphocyte DNA-binding protein that is a target for calcineurin and immunosuppressive drugs. , 1993, The Journal of biological chemistry.

[2]  M. Walkinshaw,et al.  X-ray structure of a decameric cyclophilin-cyclosporin crystal complex , 1993, Nature.

[3]  Y. Thériault,et al.  Solution structure of the cyclosporin A/cyclophilin complex by NMR , 1993, Nature.

[4]  S. Schreiber,et al.  A composite FKBP12-FK506 surface that contacts calcineurin , 1993 .

[5]  S. Schreiber,et al.  Activation of an inactive immunophilin by mutagenesis , 1993 .

[6]  C. Walsh,et al.  Active site mutants of human cyclophilin A separate peptidyl‐prolyl isomerase activity from cyclosporin A binding and calcineurin inhibition , 1992, Protein science : a publication of the Protein Society.

[7]  I. Kuntz.  Structure-Based Strategies for Drug Design and Discovery , 1992, Science.

[8]  S. Schreiber.  Immunophilin-sensitive protein phosphatase action in cell signaling pathways , 1992, Cell.

[9]  Jun O. Liu,et al.  Inhibition of T cell signaling by immunophilin-ligand complexes correlates with loss of calcineurin phosphatase activity. , 1992, Biochemistry.

[10]  G. Wider,et al.  Cyclosporin A—cyclophilin complex formation A model based on X‐ray and NMR data , 1992, FEBS letters.

[11]  S. Schreiber,et al.  The mechanism of action of cyclosporin A and FK506. , 1992, Immunology today.

[12]  D. Egan,et al.  NMR studies of [U-13C]cyclosporin A bound to cyclophilin: bound conformation and portions of cyclosporin involved in binding. , 1994, Biochemistry.

[13]  W L Jorgensen,et al.  Rusting of the lock and key model for protein-ligand binding. , 1991, Science.

[14]  Berthold Von Freyberg,et al.  Receptor-induced conformation change of the immunosuppressant cyclosporin A. , 1991, Science.

[15]  G. Crabtree,et al.  Nuclear association of a T-cell transcription factor blocked by FK-506 and cyclosporin A , 1991, Nature.

[16]  K Wüthrich,et al.  The NMR structure of cyclosporin A bound to cyclophilin in aqueous solution. , 1991, Biochemistry.

[17]  N. Sigal,et al.  Is cyclophilin involved in the immunosuppressive and nephrotoxic mechanism of action of cyclosporin A? , 1991, The Journal of experimental medicine.

[18]  L A Herzenberg,et al.  Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Horst Kessler,et al.  Reinvestigation of the Conformation of Cyclosporin A in Chloroform , 1990 .

[20]  G. Nolan,et al.  Single cell assay of a transcription factor reveals a threshold in transcription activated by signals emanating from the T-cell antigen receptor. , 1990, Genes & development.

[21]  T. Kiefhaber,et al.  Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins , 1989, Nature.

[22]  T. Hayano,et al.  Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin , 1989, Nature.

[23]  D. Rich,et al.  Synthesis, conformation, and immunosuppressive activity of a conformationally restricted cyclosporine lactam analogue. , 1988, Journal of medicinal chemistry.

[24]  S. Schreiber,et al.  Is there a scaffolding domain within the structure of the immunosuppressive agent cyclosporin a (CsA)? Studies of the cyclophilin binding domain of CsA , 1988 .

[25]  J. Baldwin,et al.  Synthesis of bicyclic γ-lactams via oxazolidinones , 1986 .

[26]  Armin Widmer,et al.  Peptide conformations. Part 31. The conformation of cyclosporin a in the crystal and in solution , 1985 .